🟢 Tscan Therapeutics is trading 5% up today amid a biotech-sector rally

Tscan Therapeutics is trading at $0.19, up 5.32%, with a biotech-sector rally the likeliest explanation for the move.

• No new company-specific announcement explaining the November 3 move was identified; Tscan’s press-release page lists no release newer than October 6.
• The biotech sector’s XBI is up 2.13%, amid a broader rotation toward biotech stocks. This supports a sector-related explanation, not a confirmed company-specific catalyst.